Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Compound Mifepristone

Home DrugsCompound Mifepristone

Compound Mifepristone

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Indications

本品与米索前列醇片序贯合并使用，可用于终止停经49天内的早期妊娠。

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

LOW-DOSE MIFEPRISTONE FOR THE TREATMENT OF ENDOMETRIOSIS ASSOCIATED PAIN
US 20260115203 A1Applicant: LABORATORIOS LITAPHAR S LPriority: 2023
EP
US
WO
4 publications
Composition and tablet of mifepristone and anorethidrane dipropionate
CN 1634078 AApplicant: SHANGHAI MODERN PHARMACEUTICALPriority: 2004
CN
Steroid compound agonist for PPARgamma and its purpose
CN 102204918 AApplicant: UNIV XIAMENPriority: 2011
CN
Novel purpose for compound
CN 102872026 AApplicant: SHANGHAI ACADEMY OF SCIENCE & TECHNOLOGYPriority: 2011
CN
Cyclodextrin mifepristone clathrate compound, preparation method thereof, and pharmaceutical composition containing clathrate compound
CN 103505740 AApplicant: SHANGHAI NEW HUALIAN PHARMACEUTICAL CO LTDPriority: 2012
CN
Treatment of Heart Failure and Sudden Cardiac Death
US 2015005269 A1Applicant: RHODE ISLAND HOSPITALPriority: 2013
US
Cap and Rep protein dual regulation and control system for producing high-quality recombinant adeno-associated virus and construction method of Cap and Rep protein dual regulation and control system
CN 120138052 AApplicant: UNIV JIANGNANPriority: 2025
CN
Yao medicine composition with effects of regulating menstruation and stopping bleeding and preparation method of Yao medicine composition
CN 121731410 AApplicant: JINXIU YAO AUTONOMOUS COUNTY YAO MEDICINE HOSPITALPriority: 2025
CN